Quantitative pathology in chemoprevention trials: standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York u.a.
Wiley-Liss
1994
|
| Schriftenreihe: | Journal of cellular biochemistry
Suppl.19 |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zs.-Heftes |
| Beschreibung: | VII, 293 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010553132 | ||
| 003 | DE-604 | ||
| 005 | 19960111 | ||
| 007 | t | ||
| 008 | 960109s1994 ad|| |||| 10||| engod | ||
| 035 | |a (OCoLC)31349979 | ||
| 035 | |a (DE-599)BVBBV010553132 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-578 | ||
| 050 | 0 | |a RC267.15 | |
| 245 | 1 | 0 | |a Quantitative pathology in chemoprevention trials |b standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate |c guest eds.: Charles W. Boone ... |
| 264 | 1 | |a New York u.a. |b Wiley-Liss |c 1994 | |
| 300 | |a VII, 293 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Journal of cellular biochemistry |v Suppl.19 | |
| 500 | |a Einzelaufnahme eines Zs.-Heftes | ||
| 650 | 7 | |a Biologische markers |2 gtt | |
| 650 | 7 | |a Chemotherapie |2 gtt | |
| 650 | 7 | |a Kanker |2 gtt | |
| 650 | 7 | |a Testen |2 gtt | |
| 650 | 4 | |a Biochemical markers | |
| 650 | 4 | |a Biological Markers | |
| 650 | 4 | |a Breast |x Cancer |x Chemoprevention | |
| 650 | 4 | |a Cancer |x Chemoprevention | |
| 650 | 4 | |a Clinical Trials | |
| 650 | 4 | |a Clinical trials | |
| 650 | 4 | |a Colon (Anatomy) |x Cancer |x Chemoprevention | |
| 650 | 4 | |a Neoplasms |x prevention & control | |
| 650 | 4 | |a Precancerous Conditions |x drug therapy | |
| 650 | 4 | |a Prostate |x Cancer |x Chemoprevention | |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tumormarker |0 (DE-588)4117262-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Prostatakrebs |0 (DE-588)4047511-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Biomonitoring |0 (DE-588)4224449-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Colonkrebs |0 (DE-588)4148225-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Prävention |0 (DE-588)4076308-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Colonkrebs |0 (DE-588)4148225-6 |D s |
| 689 | 0 | 1 | |a Tumormarker |0 (DE-588)4117262-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Prostatakrebs |0 (DE-588)4047511-6 |D s |
| 689 | 1 | 1 | |a Tumormarker |0 (DE-588)4117262-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 2 | 1 | |a Tumormarker |0 (DE-588)4117262-0 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 3 | 1 | |a Prävention |0 (DE-588)4076308-0 |D s |
| 689 | 3 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 3 | 3 | |a Biomonitoring |0 (DE-588)4224449-3 |D s |
| 689 | 3 | |5 DE-604 | |
| 700 | 1 | |a Boone, Charles W. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007035061 | ||
Datensatz im Suchindex
| _version_ | 1804125022082564096 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV010553132 |
| callnumber-first | R - Medicine |
| callnumber-label | RC267 |
| callnumber-raw | RC267.15 |
| callnumber-search | RC267.15 |
| callnumber-sort | RC 3267.15 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)31349979 (DE-599)BVBBV010553132 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02753nam a2200733 cb4500</leader><controlfield tag="001">BV010553132</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19960111 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">960109s1994 ad|| |||| 10||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)31349979</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010553132</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC267.15</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Quantitative pathology in chemoprevention trials</subfield><subfield code="b">standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate</subfield><subfield code="c">guest eds.: Charles W. Boone ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York u.a.</subfield><subfield code="b">Wiley-Liss</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VII, 293 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Journal of cellular biochemistry</subfield><subfield code="v">Suppl.19</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zs.-Heftes</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biologische markers</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Testen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemical markers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Markers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Chemoprevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemoprevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical trials</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Colon (Anatomy)</subfield><subfield code="x">Cancer</subfield><subfield code="x">Chemoprevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Precancerous Conditions</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate</subfield><subfield code="x">Cancer</subfield><subfield code="x">Chemoprevention</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumormarker</subfield><subfield code="0">(DE-588)4117262-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biomonitoring</subfield><subfield code="0">(DE-588)4224449-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Colonkrebs</subfield><subfield code="0">(DE-588)4148225-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Colonkrebs</subfield><subfield code="0">(DE-588)4148225-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Tumormarker</subfield><subfield code="0">(DE-588)4117262-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Tumormarker</subfield><subfield code="0">(DE-588)4117262-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Tumormarker</subfield><subfield code="0">(DE-588)4117262-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="3"><subfield code="a">Biomonitoring</subfield><subfield code="0">(DE-588)4224449-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boone, Charles W.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007035061</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Aufsatzsammlung Konferenzschrift |
| id | DE-604.BV010553132 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:54:57Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007035061 |
| oclc_num | 31349979 |
| open_access_boolean | |
| owner | DE-12 DE-578 |
| owner_facet | DE-12 DE-578 |
| physical | VII, 293 S. Ill., graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Wiley-Liss |
| record_format | marc |
| series2 | Journal of cellular biochemistry |
| spelling | Quantitative pathology in chemoprevention trials standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate guest eds.: Charles W. Boone ... New York u.a. Wiley-Liss 1994 VII, 293 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Journal of cellular biochemistry Suppl.19 Einzelaufnahme eines Zs.-Heftes Biologische markers gtt Chemotherapie gtt Kanker gtt Testen gtt Biochemical markers Biological Markers Breast Cancer Chemoprevention Cancer Chemoprevention Clinical Trials Clinical trials Colon (Anatomy) Cancer Chemoprevention Neoplasms prevention & control Precancerous Conditions drug therapy Prostate Cancer Chemoprevention Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Tumormarker (DE-588)4117262-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf Prostatakrebs (DE-588)4047511-6 gnd rswk-swf Biomonitoring (DE-588)4224449-3 gnd rswk-swf Colonkrebs (DE-588)4148225-6 gnd rswk-swf Prävention (DE-588)4076308-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Colonkrebs (DE-588)4148225-6 s Tumormarker (DE-588)4117262-0 s DE-604 Prostatakrebs (DE-588)4047511-6 s Brustkrebs (DE-588)4008528-4 s Krebs Medizin (DE-588)4073781-0 s Prävention (DE-588)4076308-0 s Pharmakotherapie (DE-588)4076066-2 s Biomonitoring (DE-588)4224449-3 s Boone, Charles W. Sonstige oth |
| spellingShingle | Quantitative pathology in chemoprevention trials standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate Biologische markers gtt Chemotherapie gtt Kanker gtt Testen gtt Biochemical markers Biological Markers Breast Cancer Chemoprevention Cancer Chemoprevention Clinical Trials Clinical trials Colon (Anatomy) Cancer Chemoprevention Neoplasms prevention & control Precancerous Conditions drug therapy Prostate Cancer Chemoprevention Pharmakotherapie (DE-588)4076066-2 gnd Tumormarker (DE-588)4117262-0 gnd Krebs Medizin (DE-588)4073781-0 gnd Brustkrebs (DE-588)4008528-4 gnd Prostatakrebs (DE-588)4047511-6 gnd Biomonitoring (DE-588)4224449-3 gnd Colonkrebs (DE-588)4148225-6 gnd Prävention (DE-588)4076308-0 gnd |
| subject_GND | (DE-588)4076066-2 (DE-588)4117262-0 (DE-588)4073781-0 (DE-588)4008528-4 (DE-588)4047511-6 (DE-588)4224449-3 (DE-588)4148225-6 (DE-588)4076308-0 (DE-588)4143413-4 (DE-588)1071861417 |
| title | Quantitative pathology in chemoprevention trials standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate |
| title_auth | Quantitative pathology in chemoprevention trials standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate |
| title_exact_search | Quantitative pathology in chemoprevention trials standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate |
| title_full | Quantitative pathology in chemoprevention trials standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate guest eds.: Charles W. Boone ... |
| title_fullStr | Quantitative pathology in chemoprevention trials standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate guest eds.: Charles W. Boone ... |
| title_full_unstemmed | Quantitative pathology in chemoprevention trials standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate guest eds.: Charles W. Boone ... |
| title_short | Quantitative pathology in chemoprevention trials |
| title_sort | quantitative pathology in chemoprevention trials standardization and quality control of surrogate endpoint biomarker assays for colon breast and prostate |
| title_sub | standardization and quality control of surrogate endpoint biomarker assays for colon, breast, and prostate |
| topic | Biologische markers gtt Chemotherapie gtt Kanker gtt Testen gtt Biochemical markers Biological Markers Breast Cancer Chemoprevention Cancer Chemoprevention Clinical Trials Clinical trials Colon (Anatomy) Cancer Chemoprevention Neoplasms prevention & control Precancerous Conditions drug therapy Prostate Cancer Chemoprevention Pharmakotherapie (DE-588)4076066-2 gnd Tumormarker (DE-588)4117262-0 gnd Krebs Medizin (DE-588)4073781-0 gnd Brustkrebs (DE-588)4008528-4 gnd Prostatakrebs (DE-588)4047511-6 gnd Biomonitoring (DE-588)4224449-3 gnd Colonkrebs (DE-588)4148225-6 gnd Prävention (DE-588)4076308-0 gnd |
| topic_facet | Biologische markers Chemotherapie Kanker Testen Biochemical markers Biological Markers Breast Cancer Chemoprevention Cancer Chemoprevention Clinical Trials Clinical trials Colon (Anatomy) Cancer Chemoprevention Neoplasms prevention & control Precancerous Conditions drug therapy Prostate Cancer Chemoprevention Pharmakotherapie Tumormarker Krebs Medizin Brustkrebs Prostatakrebs Biomonitoring Colonkrebs Prävention Aufsatzsammlung Konferenzschrift |
| work_keys_str_mv | AT boonecharlesw quantitativepathologyinchemopreventiontrialsstandardizationandqualitycontrolofsurrogateendpointbiomarkerassaysforcolonbreastandprostate |